WELLS DAVID B 4

4 · Trade Desk, Inc. · Filed May 15, 2025

Insider Transaction Report

Form 4

Period: 2025-05-13

Trade Desk, Inc.TTD

WELLS DAVID B

Director

Transactions

Exercise/Conversion
Class A Common Stock
2025-05-13$58.46/sh+6,990$408,621→ 73,975 total
Exercise/Conversion
Class A Common Stock
2025-05-13$58.46/sh+1,390$81,257→ 75,365 total
Exercise/Conversion
Class A Common Stock
2025-05-13$58.46/sh+220$12,861→ 76,255 total
Exercise/Conversion
Class A Common Stock
2025-05-13$58.46/sh+670$39,167→ 76,035 total
Exercise/Conversion
Class A Common Stock
2025-05-13$49.03/sh+6,826$334,679→ 83,081 total
Exercise/Conversion
Class A Common Stock
2025-05-13$49.03/sh+1,365$66,926→ 84,446 total
Exercise/Conversion
Class A Common Stock
2025-05-13$49.03/sh+655$32,115→ 85,101 total
Exercise/Conversion
Class A Common Stock
2025-05-13$66.26/sh+7,282$482,505→ 92,601 total
Exercise/Conversion
Class A Common Stock
2025-05-13$66.26/sh+1,374$91,041→ 93,975 total
Exercise/Conversion
Class A Common Stock
2025-05-13$66.26/sh+1,374$91,041→ 95,349 total
Exercise/Conversion
Class A Common Stock
2025-05-13$66.26/sh+274$18,155→ 95,623 total
Sale
Class A Common Stock
2025-05-13$79.88/sh−28,638$2,287,603→ 66,985 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-05-13−6,990→ 0 total
Exercise: $58.46Exp: 2031-05-27→ Class A Common Stock (6,990 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-05-13−1,390→ 0 total
Exercise: $58.46Exp: 2031-05-27→ Class A Common Stock (1,390 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-05-13−670→ 0 total
Exercise: $58.46Exp: 2031-05-27→ Class A Common Stock (670 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-05-13−220→ 0 total
Exercise: $58.46Exp: 2031-05-27→ Class A Common Stock (220 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-05-13−6,826→ 0 total
Exercise: $49.03Exp: 2032-05-26→ Class A Common Stock (6,826 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-05-13−1,365→ 0 total
Exercise: $49.03Exp: 2032-05-26→ Class A Common Stock (1,365 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-05-13−655→ 0 total
Exercise: $49.03Exp: 2032-05-26→ Class A Common Stock (655 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-05-13−218→ 0 total
Exercise: $49.03Exp: 2032-05-26→ Class A Common Stock (218 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-05-13−7,282→ 0 total
Exercise: $66.26Exp: 2033-05-25→ Class A Common Stock (7,282 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-05-13−1,374→ 0 total
Exercise: $66.26Exp: 2033-05-25→ Class A Common Stock (1,374 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-05-13−1,374→ 0 total
Exercise: $66.26Exp: 2033-05-25→ Class A Common Stock (1,374 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-05-13−274→ 0 total
Exercise: $66.26Exp: 2033-05-25→ Class A Common Stock (274 underlying)
Exercise/Conversion
Class A Common Stock
2025-05-13$49.03/sh+218$10,689→ 85,319 total

Footnotes (15)

[F1]These sales represent the aggregate shares from the twelve acquisitions reported above.
[F10]The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
[F11]The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
[F12]The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
[F13]The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
[F14]The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
[F15]The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F3]This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
[F4]The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
[F5]This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
[F6]This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
[F7]The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
[F8]This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
[F9]The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.

Documents

1 file

4
wk-form4_1747343118.xmlPrimary
FORM 4